[Monoclonal antibodies and chemotherapy: planning and management of symptoms].
Berardini
Rita
R
Oncologia Medica Ospedale A Cardarelli, ASL Centro Molise, Campobasso.
D000505:Alopecia / Q000139:chemically induced / Q000451:nursing; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000451:nursing; D003131:Combined Modality Therapy; D004066:Digestive System Diseases / Q000139:chemically induced / Q000451:nursing; D006402:Hematologic Diseases / Q000139:chemically induced / Q000451:nursing; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000628:therapy*; D009422:Nervous System Diseases / Q000139:chemically induced / Q000451:nursing; D010347:Patient Care Planning
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents